|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the BSX DEF 14A filed Apr 10, 2006. www.sec.gov. Our Corporate Governance Guidelines, the
charters of the standing committees of the Board, and Code of Conduct, which
applies to all of our directors, employees and officers, including the Chief
Executive Officer and Chief Financial Officer, are also available on our
website. Printed copies of these materials are available free of charge to
stockholders who request them in writing from Investor Relations at Boston
Scientific Corporation, One Boston Scientific Place, Natick, MA 01760-1537.
Information on our website or connected to it is not incorporated by reference
into this Proxy Statement.
25 This excerpt taken from the BSX 8-K filed Jan 25, 2006. www.sec.gov)
or from Boston Scientific by directing a request to Boston Scientific
Corporation, One Boston Scientific Place, Natick, Massachusetts 01760-1537,
Attention: Milan Kofol, Investor Relations, or from Guidant by directing a
request to Guidant Corporation, 111 Monument Circle, 29th Floor,
Indianapolis, Indiana 46204, Attention: Investor Relations.
Neither Boston Scientific nor Guidant is currently engaged in a solicitation of proxies from the security holders of Boston Scientific or Guidant in connection with Boston Scientific’s proposed acquisition of Guidant. If a proxy solicitation commences, Boston Scientific, Guidant and their respective directors, executive officers and other employees may be deemed to be participants in such solicitation. Information about Boston Scientific’s directors and executive officers is available in Boston Scientific’s proxy statement, dated April 4, 2005, for its 2005 annual meeting of stockholders, and information about Guidant’s directors and executive officers is available in Guidant’s most recent filing on Form 10-K. Additional information about the interests of potential participants will be included in the prospectus/proxy statement when it becomes available.
These excerpts taken from the BSX 8-K filed Jan 17, 2006. www.sec.gov) or from Boston Scientific by
directing a request to Boston Scientific Corporation, One Boston Scientific
Place, Natick, Massachusetts 01760-1537, Attention: Milan Kofol, Investor
Relations.
Boston Scientific is not currently engaged in a solicitation of proxies from the security holders of Boston Scientific or Guidant in connection with Boston Scientific’s proposed acquisition of Guidant or in connection with Johnson & Johnson’s proposed acquisition of Guidant. If a proxy solicitation commences, Boston Scientific, Guidant and their respective directors, executive officers and other employees may be deemed to be participants in such solicitation. Information about Boston Scientific’s directors and executive officers is available in Boston Scientific’s proxy statement, dated April 4, 2005, for its 2005 annual meeting of stockholders. Additional information about the interests of potential participants will be included in the prospectus/proxy statement Boston Scientific and Guidant would file if a definitive agreement with Guidant is executed.
www.sec.gov)
or from Boston Scientific by directing a request to Boston Scientific
Corporation, One Boston Scientific Place, Natick, Massachusetts 01760-1537,
Attention: Milan Kofol, Investor Relations.
Boston Scientific is not currently engaged in a solicitation of proxies from the security holders of Boston Scientific or Guidant in connection with Boston Scientific’s proposed acquisition of Guidant or in connection with Johnson & Johnson’s proposed acquisition of Guidant. If a proxy solicitation commences, Boston Scientific, Guidant and their respective directors, executive officers and other employees may be deemed to be participants in such solicitation. Information about Boston Scientific’s directors and executive officers is available in Boston Scientific’s proxy statement, dated April 4, 2005, for its 2005 annual meeting of stockholders. Additional information about the interests of potential participants will be included in the prospectus/proxy statement Boston Scientific and Guidant would file if a definitive agreement with Guidant is executed.
This excerpt taken from the BSX 8-K filed Jan 13, 2006. www.sec.gov)
or from Boston Scientific by directing a request to Boston Scientific
Corporation, One Boston Scientific Place, Natick, Massachusetts 01760-1537,
Attention: Milan Kofol, Investor Relations.
Boston Scientific is not currently engaged in a solicitation of proxies from the security holders of Boston Scientific or Guidant in connection with Boston Scientific’s proposed acquisition of Guidant or in connection with Johnson & Johnson’s proposed acquisition of Guidant. If a proxy solicitation commences, Boston Scientific, Guidant and their respective directors, executive officers and other employees may be deemed to be participants in such solicitation. Information about Boston Scientific’s directors and executive officers is available in Boston Scientific’s proxy statement, dated April 4, 2005, for its 2005 annual meeting of stockholders. Additional information about the interests of potential participants will be included in the prospectus/proxy statement Boston Scientific and Guidant would file if a definitive agreement with Guidant is executed.
These excerpts taken from the BSX 8-K filed Jan 10, 2006. www.sec.gov) or from Boston Scientific by
directing a request to Boston Scientific Corporation, One Boston Scientific
Place, Natick, Massachusetts 01760-1537, Attention: Milan Kofol, Investor
Relations.
3
Boston Scientific is not currently engaged in a solicitation of proxies from the security holders of Boston Scientific or Guidant in connection with Boston Scientific’s proposed acquisition of Guidant or in connection with Johnson & Johnson’s proposed acquisition of Guidant. If a proxy solicitation commences, Boston Scientific, Guidant and their respective directors, executive officers and other employees may be deemed to be participants in such solicitation. Information about Boston Scientific’s directors and executive officers is available in Boston Scientific’s proxy statement, dated April 4, 2005, for its 2005 annual meeting of stockholders. Additional information about the interests of potential participants will be included in the prospectus/proxy statement Boston Scientific and Guidant would file if a definitive agreement with Guidant is executed.
www.sec.gov) or from Boston Scientific by
directing a request to Boston Scientific Corporation, One Boston Scientific
Place, Natick, Massachusetts 01760-1537, Attention: Milan Kofol, Investor
Relations.
Boston Scientific is not currently engaged in a solicitation of proxies from the security holders of Boston Scientific or Guidant in connection with Boston Scientific’s proposed acquisition of Guidant or in connection with Johnson & Johnson’s proposed acquisition of Guidant. If a proxy solicitation commences, Boston Scientific, Guidant and their respective directors, executive officers and other employees may be deemed to be participants in such solicitation. Information about Boston Scientific’s directors and executive officers is available in Boston Scientific’s proxy statement, dated April 4, 2005, for its 2005 annual meeting of stockholders. Additional information about the interests of potential participants will be included in the prospectus/proxy statement Boston Scientific and Guidant would file if a definitive agreement with Guidant is executed.
This excerpt taken from the BSX 8-K filed Dec 5, 2005. www.sec.gov)
or from Boston Scientific by directing a request to Boston Scientific
Corporation, One Boston Scientific Place, Natick, Massachusetts 01760-1537,
Attention: Milan Kofol, Investor Relations.
6
Boston Scientific is not currently engaged in a solicitation of proxies from the securityholders of Boston Scientific or Guidant in connection with Boston Scientific’s proposed acquisition of Guidant or in connection with Johnson & Johnson’s proposed acquisition of Guidant. If a proxy solicitation commences, Boston Scientific, Guidant and their respective directors, executive officers and other employees may be deemed to be participants in such solicitation. Information about Boston Scientific’s directors and executive officers is available in Boston Scientific’s proxy statement, dated April 4, 2005, for its 2005 annual meeting of stockholders. Additional information about the interests of potential participants will be included in the prospectus/proxy statement Boston Scientific and Guidant would file if a definitive agreement with Guidant is executed.
| EXCERPTS ON THIS PAGE:
|
| |||||||
